EP 67: Designing Health into Everyday Life | Steve Downs & Thomas Goetz

Is the everyday world making us sick? Can we hold companies responsible for the health consequences of their products and services? How do you design health into the operating systems of our civilization? Steve Downs is a co-founder at Building H, a project to build health into everyday life. Steve, his Building H co-founder Thomas Goetz, and other collaborators are growing a community of entrepreneurs, investors, designers, engineers and researchers who believe that we need to re-imagine everyday life—how we eat, sleep, get from place to place, socialize and entertain ourselves—to be healthy by design. In addition to community building, Building H and their collaborators are developing tools to help companies understand the impacts of their products and services on the health and well-being of their users. Steve is a lecturer at the d.school at Stanford University and an adjunct faculty member at the Interactive Telecommunications Program (ITP) at NYU’s Tisch School of the Arts. Prior to his role at Building H, he was the chief technology and strategy officer at Robert Wood Johnson Foundation (RWJF) where he focused on the practice of program strategy and on the alignment of the Foundation’s technology strategy and operations with its organizational directions. Recognizing that RWJF’s pursuit of its ambitious Culture of Health vision required an approach to strategy that is highly flexible and adaptive, he led a transformation of the Foundation’s approach to program strategy. Born in New Hampshire, Steve earned an SM in technology and policy from the Massachusetts Institute of Technology and a BS in physics and applied physics from Yale University. Thomas Goetz is a journalist, author and entrepreneur. He uses data, design, and stories to help people understand and navigate complicated issues in their lives. Thomas is the co-founder of Iodine, an award-winning website that helps people make sense of their health and medicines. In 2016, Iodine was acquired by GoodRx, America’s leading source for prescription drug